1. Home
  2. Medical Research
  3. Washington, DC
  4. Society for Neuroscience
AMERICA'S BEST NONPROFITS 2026

Society for Neuroscience

Society for Neuroscience is ranked #2 of 16 medical research organizations in Washington, DC, with an America's Best Score of 94 out of 100, based on its 2025 Form 990. It's named America's Best 2026.

  • Washington, DC
  • Tax-exempt since 1970
  • EIN: 52-0895843
sfn.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
94OF 100 #2 of 16 in Washington ranked medical research organizations How this score is calculated

Organization summary

Society for Neuroscience is a 501(c)(3) organization, classified under Medical Research (NTEE H030). Contributions are tax-deductible.

1121 14Th St Nw Ste 1010, Washington, DC 20005-5642

Among the 27 scored medical research organizations in Washington, Society for Neuroscience holds 41.5 months of operating reserves (peer median 12.1 months), runs a typical yearly surplus of 24.8% (peers: surplus of 8.2%), and has grown spending 9.6% a year (peers: grown spending 7.7% a year).

In fiscal year 2025 it reported $36,716,820 in revenue and $29,419,966 in expenses, with contributions making up 9.7% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

Sfn's mission is to: 1. Advance the understanding of the brain and the nervous system by bringing together scientists of all segments of neuroscience, by facilitating the integration of research directed at all levels of biological organization, (continued on schedule o)

Largest programs · fiscal year 2025

  • Annual meeting: The premier venue for neuroscientists from around the world to confer and discuss the latest advances in the science of the brain and the nervous system. $10,083,233 spent · 47.2% of program spending
  • General program service: To provide professional development activities and educational resources for neuroscientists, to promote public information and general education about the nature of scientific discovery and the results and implications of the latest neuroscience research. $8,037,332 spent · 37.6% of program spending
  • Journal of neuroscience mission is to publish excellent science that can be discussed, debated, studied, and built upon to advance the understanding of the brain and the nervous system. At the core of eneuro is a commitment to provide authors with a fair assessment of their work, with any additional experiments requested thoroughly justified, while maintaining high standards of peer review. $2,708,499 spent · 12.7% of program spending
  • Federal grants: To provide professional development and educational resources for neuroscientists. $533,193 spent · 2.5% of program spending

Where each dollar went · fiscal year 2025

Of every dollar it spent, 73¢ went to programs, 27¢ to management and 0¢ to fundraising.

  • Programs $21,362,257
  • Management $8,057,709
  • Fundraising $0

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score94 / 100
Rank in Washington#2 of 16
DesignationAmerica's Best 2026

Score breakdown

MeasureThis organizationPoints
Operating reserves41.5 mo; 3.3 mo in cash25 / 25
Financial balance (median margin)+24.8%19.6 / 20
Transparency3 full 990s, latest TY202520 / 20
Program growth+9.6% / yr12.3 / 15
Track record56 years10 / 10
Debt load24.3% of assets7.1 / 10
Total94 → 94
Spending on programs
Not scored; America's Best needs 65%+
73%Meets

Compared with Washington peers

MeasureThis organizationPeer median
Operating reserves41.5 mo12.1 mo
Typical margin+24.8%+8.2%
Spending growth+9.6% / yr+7.7% / yr
Debt load24.3%11.4%

Peers: the 27 Washington medical research organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$36,716,820Fiscal year 20252022: $23,945,25220222023: $41,752,83220232025: $36,716,8202025
Expenses$29,419,966Fiscal year 20252022: $22,346,54420222023: $26,696,08520232025: $29,419,9662025
Total assets$134,571,669Fiscal year 20252022: $113,261,71820222023: $119,118,16920232025: $134,571,6692025
Total liabilities$32,754,636Fiscal year 20252022: $54,057,32820222023: $36,507,91920232025: $32,754,6362025
Fiscal year ending June 2025
Revenue$36,716,820
Expenses$29,419,966
Net income$7,296,854
Net assets$101,817,033

Notable sources of revenue

Percent of total revenue
Contributions$3,562,604
Program services$26,248,054
Investment income$3,665,696
Other (net)$3,240,466

Assets / debt

Total assets$134,571,669
Total liabilities$32,754,636
Net assets$101,817,033

Compensation

Not in our extract for this year.

Fiscal year ending June 2023
Revenue$41,752,832
Expenses$26,696,085
Net income$15,056,747
Net assets$82,610,250

Notable sources of revenue

Percent of total revenue
Contributions$4,615,882
Program services$26,551,809
Investment income$1,728,074
Other (net)$8,857,067

Assets / debt

Total assets$119,118,169
Total liabilities$36,507,919
Net assets$82,610,250

Compensation

Officers and key employees$2,597,135
Share of expenses9.7%
Fiscal year ending June 2022
Revenue$23,945,252
Expenses$22,346,544
Net income$1,598,708
Net assets$59,204,390

Notable sources of revenue

Percent of total revenue
Contributions$2,820,303
Program services$18,606,452
Investment income$1,487,060
Other (net)$1,031,437

Assets / debt

Total assets$113,261,718
Total liabilities$54,057,328
Net assets$59,204,390

Compensation

Officers and key employees$2,094,446
Share of expenses9.4%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?